Using computer predictions based on averaged kinetic parameters, Noorduin and colleagues [14] examined infusion regimens aimed at providing adequate peroperative analgesia whilst avoiding postoperative respiratory depression. Their recommendation for surgery under general anaesthesia was: a fixed rate maintenance infusion of alfentanil 1 ng kg" 1 min" 1 preceded by a loading bolus injection of lOOugkg" 1 . This should give a therapeutically adequate plasma concentration, at steady state, of 300 ng ml" 1 [15] . The present study was designed to evaluate these predictions in a patient population with the widest acceptable age range and duration of major peripheral surgery.
PATIENTS AND METHODS
Twenty-nine patients (19 female) gave verbal consent to participate in the study, which was approved by the local Ethics Committee. All patients were ASA I or II without impairment of hepatic or renal function, and were scheduled for orthopaedic surgery (table I) bolus. An infusion of vecuronium was started and the infusion rate was adapted to give single twitch depression of 50-75%. An additional bolus of alfentanil 1 mg was given if an increase in arterial pressure or heart rate of more than 10% greater than baseline occurred or if the patient responded in other ways to surgical stimulation. The infusions of alfentanil and vecuronium were stopped approximately 20 min before the end of the operation.
Blood samples were obtained from a 20-gauge Teflon cannula inserted into a radial artery, immediately before the first bolus injection of alfentanil and at 5, 10, 20, 30, 45, 60 and every subsequent 30 min during the infusion; further immediately before and 3 and 5 min after each supplementary bolus; and finally 3, 10, 30, 60 and every subsequent 60 min for 8 h after cessation of the infusion.
Analysis
Concentrations of alfentanil in plasma were measured by a specific radioimmunoassay [16] . The detection limit of the assay was 1 ng/ml plasma. The accuracy and reproducibility of the radioimmunoassay were within 5%. Pharmacokinetic parameters were calculated by two methods: a model-independent approach (MI) and curve fitting (FIT) using standard one-, twoor three-compartment analysis.
In the model-independent approach, the terminal half-life (Tf) and the pharmacokinetic parameters based on the area under the plasma concentration-time curve were calculated. 7"j p was obtained as 0.693/P, where P is the slope of the terminal log-linear plasma concentration-time data. The total area under the plasma concentration-time curve (AUGo-co) was estimated as AUCo_ OT = AUC 0 _, + C ( /P where AUC 0 _, was obtained using trapezoidal summation to the last plasma concentration (C,).
All plasma concentration-time curves of alfentanil were fitted to a standard multiexponential equation for a set of i.v. bolus doses and a continuous infusion [17] . Compartmental volume (VJ, a, P and k 2l were obtained using extended least-squares non-linear regression (ELSFIT) [18] . The appropriate compartmental model was selected by evaluation of the standard errors on the parameter estimates, scatterplots of the residuals between experimental and predicted plasma data and the maximum likelihood function. All other pharmacokinetic parameters were derived using standard methods [17] .
The relationships between the relevant pharmacokinetic parameters and variables such as infusion duration, total dose, age and body weight were investigated by linear regression analysis [19] .
The estimated steady state concentration (the plasma concentration that would have been reached if the infusion had continued long enough for steady state to be attained) was calculated using the formula: concentration = infusion rate/ clearance.
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Effects of body weight
There was no significant relationship between clearance or volume of distribution and body weight.
Effects of age
Fd ss was significantly enlarged with increasing age (P = 0.003). Clearance did not correlate significantly with age (P = 0.16). Age had a linear effect on 7V 3 in the patients older than 40 yr (P = 0.0006). A correlation was not shown in the patients younger than 40 yr (P = 0.74).
Steady state concentration
The mean estimated steady state concentration was 293 (SD 132) ng ml" 1 (range 147-636 ng ml" 1 ).
RESULTS
Pharmacokinetic analysis
The pharmacokinetic parameters obtained by the model-independent approach and by curvefitting are listed in tables II and III, and the twosided 95 % confidence intervals (t x SEM) for the mean absolute differences between both methods expressed as a percentage of MI are 2-5 % for Cl and 8-15% for Tg and Fd area (table IV) . The time course of the alfentanil plasma concentration fitted a two-compartmental model in 26 patients. The plasma concentration data of three patients (Nos 4, 7 and 18) could not be fitted adequately by any compartmental model. We were able to show in the 26 patients whose data could be fitted by both methods that there was no relevant difference between parameters found with our curve-fitting method and those found using a model-independent analysis.
There was a wide variation in Tfi values which ranged from 56 to 226 min. The highest values were found mostly in the age group older than 60 yr.
Effects of dose or duration of the infusion
The duration of the infusions ranged from 44 to 445 min. Total dose ranged from 10.1 to 45.3 mg. There was no significant correlation between the pharmacokinetic parameters (Tf, Cl, V c , Vd ss , Fd area ) and the duration of the infusion, or with the total dose including all supplementary i.v. bolus doses. 
DISCUSSION
Our kinetic parameters correlate well with values obtained in earlier studies after a single dose [1] [2] [3] [4] [5] [6] [7] or an infusion [11] [12] [13] . The average T£ was of the order of 2 h and Cl was approximately 4 ml kg" 1 min" 1 in young to middle-age subjects. In the present study, data of 26 patients were fitted to a two-compartmental model and those from three patients could not be fitted adequately to any compartmental model. Plasma concentrations after a single bolus injection can usually be fitted to a two-compartmental [3] [4] [5] or to a three-compartmental model [1, 2] . However, it is well known that after cessation of an infusion the initial, fast distribution phase is reduced and is discriminated less easily in the total plasma concentration-time profile. This could explain why a three-compartmental model did not improve the fit over a two-compartmental analysis in the present study or in any other infusion study of alfentanil [12, 13] . Shafer, Sung and White [12] found no correlation between clearance and duration of infusion and reported also that the pharmacokinetics were independent of the maintenance infusion rate (0.25-1.3 ug kg" 1 min" 1 ), duration of the infusion (59-385 min), body weight (40-113 kg), age (18-59 yr), sex or type of surgery (superficial or intraabdominal). In contrast, Reitz and colleagues [13] claimed there is a decrease in clearance and a prolonged half-life with increasing duration of surgery. Visual inspection of their published data reveals no correlation in the nine patients undergoing surgery for less than 150 min and an increase in TP and a decrease in Cl in only two patients with surgery lasting for 212 and 335 min, respectively. The present study shows that the pharmacokinetics of alfentanil given by i.v. infusion are independent of the duration of the infusion (in our study 44-445 min) and the total dose given (10.1-45.3 mg). Consequently, our data and those of Shafer do not confirm the conclusion drawn by Reitz.
One factor known to change the disposition of alfentanil is age. Helmers [4] found prolonged Tâ nd reduced clearance of alfentanil after a single bolus dose in the elderly. In addition, the population pharmacokinetic analysis by Maitre on single-dose data [8] , which included the Helmers data from elderly patients, revealed age-related reductions in clearance and a slower redistribution from the deep compartment. With an alfentanil infusion, Shafer's group [12] found no correlation between age and pharmacokinetic parameters, but it has to be stressed that the ages of their patients ranged from 18 to 59 yr. Scott and Stanski [20] reported increased Tfi with age, but they did not find clearance values significantly affected by age. It should be noted that a very short infusion of alfentanil 1500 ug min" 1 was given for approximately 5 min, and these data should be considered rather as a slowly given bolus than as a continuous infusion.
Our findings are similar to those of Scott and Stanski [20] , with TP increased significantly in subjects older than 55 yr, but no significant linear correlation between clearance and age. One reason for the lack of correlation with clearance is probably that this tends to be more variable during a continuous infusion in long-term surgery than after a single bolus injection.
Both the loading dose and maintenance infusion rate in this study were calculated on the basis of body weight, as is conventional practice. The population pharmacokinetic analysis after a single bolus dose by Maitre revealed a significant effect of body weight on the volume of distribution of the central compartment, but not on clearance. In our study, plasma clearance and volumes of distribution (Vd ss and Fd area ) did not correlate significantly with body weight.
According to the findings of Ausems and colleagues [15] , for adequate pain relief the concentration at steady state should be of the order of SOOngml" 1 . The mean value of the calculated alfentanil steady-state concentration averaged 293 ng ml" 1 in our study. It indicates that the proposed 100-ug kg" 1 loading dose and infusion of 1 \ig kg" 1 min" 1 may be an appropriate regimen for analgesia in general surgical procedures. As in the present study, transient periods of inadequate analgesia (indicated by hypertension and tachycardia) may be treated by the use of additional i.v. bolus doses of alfentanil 1 mg.
